Literature DB >> 30932478

Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.

Walid M Abdelmoula1, Michael S Regan1, Begona G C Lopez1, Elizabeth C Randall2, Sean Lawler1, Ann C Mladek3, Michal O Nowicki1, Bianca M Marin3, Jeffrey N Agar4, Kristin R Swanson5, Tina Kapur2, Jann N Sarkaria3, William Wells2,6, Nathalie Y R Agar1,2,7.   

Abstract

Multimodal integration between mass spectrometry imaging (MSI) and radiology-established modalities such as magnetic resonance imaging (MRI) would allow the investigations of key questions in complex biological systems such as the central nervous system. Such integration would provide complementary multiscale data to bridge the gap between molecular and anatomical phenotypes, potentially revealing new insights into molecular mechanisms underlying anatomical pathologies presented on MRI. Automatic coregistration between 3D MSI/MRI is a computationally challenging process due to dimensional complexity, MSI data sparsity, lack of direct spatial-correspondences, and nonlinear tissue deformation. Here, we present a new computational approach based on stochastic neighbor embedding to nonlinearly align 3D MSI to MRI data, identify and reconstruct biologically relevant molecular patterns in 3D, and fuse the MSI datacube to the MRI space. We demonstrate our method using multimodal high-spectral resolution matrix-assisted laser desorption ionization (MALDI) 9.4 T MSI and 7 T in vivo MRI data, acquired from a patient-derived, xenograft mouse brain model of glioblastoma following administration of the EGFR inhibitor drug of Erlotinib. Results show the distribution of some identified molecular ions of the EGFR inhibitor erlotinib, a phosphatidylcholine lipid, and cholesterol, which were reconstructed in 3D and mapped to the MRI space. The registration quality was evaluated on two normal mouse brains using the Dice coefficient for the regions of brainstem, hippocampus, and cortex. The method is generic and can therefore be applied to hyperspectral images from different mass spectrometers and integrated with other established in vivo imaging modalities such as computed tomography (CT) and positron emission tomography (PET).

Entities:  

Year:  2019        PMID: 30932478      PMCID: PMC6691508          DOI: 10.1021/acs.analchem.9b00854

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  48 in total

Review 1.  A survey of medical image registration.

Authors:  J B Maintz; M A Viergever
Journal:  Med Image Anal       Date:  1998-03       Impact factor: 8.545

2.  Fusion of autoradiographs with an MR volume using 2-D and 3-D linear transformations.

Authors:  Grégoire Malandain; Eric Bardinet; Koen Nelissen; Wim Vanduffel
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

Review 3.  Imaging mass spectrometry: fundamentals and applications to drug discovery.

Authors:  Stanislav S Rubakhin; John C Jurchen; Eric B Monroe; Jonathan V Sweedler
Journal:  Drug Discov Today       Date:  2005-06-15       Impact factor: 7.851

Review 4.  MALDI MS imaging of amyloid.

Authors:  Markus Stoeckli; Richard Knochenmuss; Gregor McCombie; Dieter Mueller; Tatiana Rohner; Dieter Staab; Karl-Heinz Wiederhold
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

5.  Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging.

Authors:  Tuhin K Sinha; Sheerin Khatib-Shahidi; Thomas E Yankeelov; Khubaib Mapara; Moneeb Ehtesham; D Shannon Cornett; Benoit M Dawant; Richard M Caprioli; John C Gore
Journal:  Nat Methods       Date:  2007-12-16       Impact factor: 28.547

6.  Imaging mass spectrometry.

Authors:  Liam A McDonnell; Ron M A Heeren
Journal:  Mass Spectrom Rev       Date:  2007 Jul-Aug       Impact factor: 10.946

7.  Mass spectrometry sampling under ambient conditions with desorption electrospray ionization.

Authors:  Zoltán Takáts; Justin M Wiseman; Bogdan Gologan; R Graham Cooks
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

8.  Registration methodology for histological sections and in vivo imaging of human prostate.

Authors:  Hyunjin Park; Morand R Piert; Asra Khan; Rajal Shah; Hero Hussain; Javed Siddiqui; Thomas L Chenevert; Charles R Meyer
Journal:  Acad Radiol       Date:  2008-08       Impact factor: 3.173

9.  Molecular imaging of proteins in tissues by mass spectrometry.

Authors:  Erin H Seeley; Richard M Caprioli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-05       Impact factor: 11.205

10.  HMDB: the Human Metabolome Database.

Authors:  David S Wishart; Dan Tzur; Craig Knox; Roman Eisner; An Chi Guo; Nelson Young; Dean Cheng; Kevin Jewell; David Arndt; Summit Sawhney; Chris Fung; Lisa Nikolai; Mike Lewis; Marie-Aude Coutouly; Ian Forsythe; Peter Tang; Savita Shrivastava; Kevin Jeroncic; Paul Stothard; Godwin Amegbey; David Block; David D Hau; James Wagner; Jessica Miniaci; Melisa Clements; Mulu Gebremedhin; Natalie Guo; Ying Zhang; Gavin E Duggan; Glen D Macinnis; Alim M Weljie; Reza Dowlatabadi; Fiona Bamforth; Derrick Clive; Russ Greiner; Liang Li; Tom Marrie; Brian D Sykes; Hans J Vogel; Lori Querengesser
Journal:  Nucleic Acids Res       Date:  2007-01       Impact factor: 16.971

View more
  14 in total

1.  Spatial Metabolomics and Imaging Mass Spectrometry in the Age of Artificial Intelligence.

Authors:  Theodore Alexandrov
Journal:  Annu Rev Biomed Data Sci       Date:  2020-04-13

Review 2.  Applications and continued evolution of glycan imaging mass spectrometry.

Authors:  Colin T McDowell; Xiaowei Lu; Anand S Mehta; Peggi M Angel; Richard R Drake
Journal:  Mass Spectrom Rev       Date:  2021-08-15       Impact factor: 10.946

3.  Discovering New Lipidomic Features Using Cell Type Specific Fluorophore Expression to Provide Spatial and Biological Specificity in a Multimodal Workflow with MALDI Imaging Mass Spectrometry.

Authors:  Marissa A Jones; Sung Hoon Cho; Nathan Heath Patterson; Raf Van de Plas; Jeffrey M Spraggins; Mark R Boothby; Richard M Caprioli
Journal:  Anal Chem       Date:  2020-05-06       Impact factor: 6.986

Review 4.  ADVANCES IN HIGH-RESOLUTION MALDI MASS SPECTROMETRY FOR NEUROBIOLOGY.

Authors:  Kellen DeLaney; Ashley Phetsanthad; Lingjun Li
Journal:  Mass Spectrom Rev       Date:  2020-11-09       Impact factor: 10.946

5.  M2aia-Interactive, fast, and memory-efficient analysis of 2D and 3D multi-modal mass spectrometry imaging data.

Authors:  Jonas Cordes; Thomas Enzlein; Christian Marsching; Marven Hinze; Sandy Engelhardt; Carsten Hopf; Ivo Wolf
Journal:  Gigascience       Date:  2021-07-20       Impact factor: 6.524

Review 6.  Mass Spectrometry Imaging of Fibroblasts: Promise and Challenge.

Authors:  Peggi M Angel; Denys Rujchanarong; Sarah Pippin; Laura Spruill; Richard Drake
Journal:  Expert Rev Proteomics       Date:  2021-07-24       Impact factor: 4.250

Review 7.  Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.

Authors:  Calvin R K Blaschke; Colin T McDowell; Alyson P Black; Anand S Mehta; Peggi M Angel; Richard R Drake
Journal:  Clin Lab Med       Date:  2021-04-24       Impact factor: 2.172

8.  Rapid MALDI mass spectrometry imaging for surgical pathology.

Authors:  Sankha S Basu; Michael S Regan; Elizabeth C Randall; Walid M Abdelmoula; Amanda R Clark; Begoña Gimenez-Cassina Lopez; Dale S Cornett; Andreas Haase; Sandro Santagata; Nathalie Y R Agar
Journal:  NPJ Precis Oncol       Date:  2019-07-04

9.  Light sheet fluorescence microscopy guided MALDI-imaging mass spectrometry of cleared tissue samples.

Authors:  Andreas Blutke; Na Sun; Zhihao Xu; Achim Buck; Luke Harrison; Sonja C Schriever; Paul T Pfluger; David Wiles; Thomas Kunzke; Katharina Huber; Jürgen Schlegel; Michaela Aichler; Annette Feuchtinger; Kaspar Matiasek; Stefanie M Hauck; Axel Walch
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

Review 10.  Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.

Authors:  Josanne Sophia de Maar; Alexandros Marios Sofias; Tiffany Porta Siegel; Rob J Vreeken; Chrit Moonen; Clemens Bos; Roel Deckers
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.